Roledumab

Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1]

Roledumab
Monoclonal antibody
Type	Whole antibody
Source	Human
Target	RHD
Clinical data
ATC code	none
Identifiers
CAS Number	1174008-79-7^N
ChemSpider	none
^NY (what is this?) (verify)

It is currently at Phase III trials for Rh disease.

References

World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.